Laser plus Geniwa gel for recurring genital warts
Part of Infections, Skin clinical trials.
This trial tests whether adding a special gel (Geniwa gel) to standard laser treatment helps prevent genital warts from coming back. It may be an option for people who have already tried laser treatment but their warts returned.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Aged 18 years or older
- Have genital or anal warts that are clearly visible
- Have had at least 2 laser treatments in the past, and your warts came back after that
- Have at least 4 warts, or the wart area is at least 0.5 square centimeters
- Do not have an active sexually transmitted infection like gonorrhea, syphilis, or genital herpes
- Not be pregnant or allergic to any ingredient in the gel
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of a medication called peginterferon alfa-2b and a CO2 laser to treat genital warts. It may help reduce the chance of warts coming back after laser removal.
This study is testing a vaginal gel that might help restore the health of the cervix in women who have HPV. If you have HPV and your cervical cells are normal or only mildly abnormal, you may be able to join.
This study tests whether an HPV vaccine can help shrink or clear cutaneous (skin) warts that have not responded to prior treatments. Participants get the study vaccine or a placebo to compare results and safety.
This trial tests three treatments for common skin warts: platelet-rich plasma injections (using your own blood components), a metformin cream, and cryotherapy (freezing). It aims to find which works best and is safest. If you have warts on your skin (not genital), you may be able to join.
This trial tests whether applying heat combined with a common disinfectant (hydrogen peroxide) can safely and effectively remove viral skin warts. It may be an option if you have common, plantar, or genital warts and are between 16 and 65 years old.
This Phase 3 trial tests a nonavalent HPV vaccine to treat long-lasting, hard-to-treat warts on the hands or feet. If you have tried standard treatments and the warts keep coming back or cause trouble, the vaccine may help your body clear the warts.
Hear when a new HPV (Human Papillomavirus)-Associated trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.